Search
Copyright © 2025 ALM Global, LLC. All Rights Reserved.
Dr. Peter Marks has just resigned from his position as Director of Center for Biologics Evaluation and Research at the Food and Drug Administration. Photo: Susan Walsh/APThe Food and Drug Administration’s top vaccine regulator abruptly resigned Friday, citing what he called Health and Human Services Secretary Robert F. Kennedy Jr.’s efforts to spread misinformation about the safety of immunizations, according to a letter obtained by Bloomberg.
Peter Marks, who was a key figure in Operation Warp Speed, stepped down from his position as the director of the FDA’s Center for Biologics Evaluation and Research, which is responsible for the safety and effectiveness of vaccines, along with gene therapies and blood products.
Already have an account? Sign In Now
NOT FOR REPRINT
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Guide
Sponsored by Zelis
The Do's and Don'ts of Improved Data Accuracy
Inaccurate provider data can lead to frustrated clients and stress on your business relationships. These are the top do’s and don’ts to ensure the data you rely on as a benefits advisor is as accurate and helpful as possible.
Guide
Sponsored by LifeSecure Insurance Company
7 Must-Haves That Employers (and Employees!) Want in Workplace Benefits in 2025
Employers are revamping their benefits strategies--but are they offering what employees truly want? Discover the seven key elements shaping workplace benefits in 2025 to help your clients enhance satisfaction, retention, and enrollment.
Guide
Sponsored by Nonstop Administration and Insurance Services, Inc.
Guide: Redefining the Role of the Broker
In 2025, you are uniquely positioned to make a real difference for your clients--both financially and in the wellness of their employees. Full of tips ranging from goal setting to relationship building, this is your guide to being a better partner this year, and beyond.
Copyright © 2025 ALM Global, LLC. All Rights Reserved.
Sign In
Sign In
